Avivagen Announces the Issuance of Shares
02 mai 2018 16h30 HE
|
Avivagen Inc.
OTTAWA, May 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference
01 mai 2018 16h30 HE
|
Avivagen Inc.
OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces OxC-beta™ Purchase Order with New Customer
25 avr. 2018 06h30 HE
|
Avivagen Inc.
OTTAWA, April 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”) is a life sciences corporation focused on developing and commercializing...
Avivagen Announces the Issuance of Stock Options
13 avr. 2018 16h15 HE
|
Avivagen Inc.
OTTAWA, April 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces Results from Its Annual General Meeting
10 avr. 2018 16h30 HE
|
Avivagen Inc.
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces an Amendment to its Stock Option Plan
05 avr. 2018 06h30 HE
|
Avivagen Inc.
OTTAWA, April 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta™ Livestock in the Philippines
26 mars 2018 06h30 HE
|
Avivagen Inc.
OTTAWA, March 26, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...
Cesar Millan’s Highly Recommended Vivamune™ Scheduled for Global Pet Expo Debut
19 mars 2018 06h30 HE
|
Avivagen Inc.
OTTAWA, March 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants
12 mars 2018 06h30 HE
|
Avivagen Inc.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, March 12, 2018 ...
Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results
27 févr. 2018 06h30 HE
|
Avivagen Inc.
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...